Trial Profile
A trial of early response to risperidone treatment in the first episode of schizophrenia (FES) patients and its predictive value to subsequent response
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 22 Dec 2015 New trial record